Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Devogelaer

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Arthritis and Rheumatism|June 12, 1999
Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesionsD H Manicourt, R D Altman, J M Williams, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 31, 2010
A FRAX® model for the assessment of fracture probability in BelgiumH Johansson, J A Kanis, E V McCloskey, et al.
Annals of the Rheumatic Diseases|October 30, 2007
Effects of strontium ranelate on spinal osteoarthritis progressionO Bruyere, D Delferriere, C Roux, et al.
Revue Medicale De Liege|February 11, 2010
[A FRAX model for the assessment of fracture probability in Belgium]A Neuprez, H Johansson, J A Kanis, et al.
Clinical Orthopaedics and Related Research|April 1, 1987
New modes of administration of salmon calcitonin in Paget's disease. Nasal spray and suppositoryC Nagant de Deuxchaisnes, J P Devogelaer, J P Huaux, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 7, 2011
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosisC Roux, D M Reid, J-P Devogelaer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 10, 2014
Goal-directed treatment of osteoporosis in EuropeJ A Kanis, E McCloskey, J Branco, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1982
Inhibition of cytochemical bioactivity of parathyroid hormone by plasma in pseudohypoparathyroidism type IN Loveridge, J A Fischer, C Nagant de Deuxchaisnes, et al.
Rheumatology (Oxford, England)|February 8, 2005
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective studyP Durez, F Van den Bosch, L Corluy, et al.
Calcified Tissue International|May 28, 2004
Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's diseaseG Beyens, E Van Hul, K Van Driessche, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Arthritis and Rheumatism|June 12, 1999
Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesionsD H Manicourt, R D Altman, J M Williams, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 31, 2010
A FRAX® model for the assessment of fracture probability in BelgiumH Johansson, J A Kanis, E V McCloskey, et al.
Annals of the Rheumatic Diseases|October 30, 2007
Effects of strontium ranelate on spinal osteoarthritis progressionO Bruyere, D Delferriere, C Roux, et al.
Revue Medicale De Liege|February 11, 2010
[A FRAX model for the assessment of fracture probability in Belgium]A Neuprez, H Johansson, J A Kanis, et al.
Clinical Orthopaedics and Related Research|April 1, 1987
New modes of administration of salmon calcitonin in Paget's disease. Nasal spray and suppositoryC Nagant de Deuxchaisnes, J P Devogelaer, J P Huaux, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 7, 2011
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosisC Roux, D M Reid, J-P Devogelaer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 10, 2014
Goal-directed treatment of osteoporosis in EuropeJ A Kanis, E McCloskey, J Branco, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1982
Inhibition of cytochemical bioactivity of parathyroid hormone by plasma in pseudohypoparathyroidism type IN Loveridge, J A Fischer, C Nagant de Deuxchaisnes, et al.
Rheumatology (Oxford, England)|February 8, 2005
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective studyP Durez, F Van den Bosch, L Corluy, et al.
Calcified Tissue International|May 28, 2004
Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's diseaseG Beyens, E Van Hul, K Van Driessche, et al.
Pageof 14